BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

BiomX

BiomX logo

Founded
2015
Geography
Israel based
Funding
$56 M

BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators: Professor Rotem Sorek, PhD and Dr. Eran Elinav, MD, PhD both of the Weizmann Institute of Science and Professor Timothy K. Lu, MD, PhD of the Massachusetts Institute of Technology.

Technologies

Microbiome Startups  


Posts Mentioning This Company

Biopharma Insights

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet